095, 0.096) 0.65 0.034 (−0.039, 0.104) 0.13 0.004 (−0.090, 0.099) 0.96 Female −0.027 (−0.111, 0.054) −0.038 (−0.096, 0.021) 0.001 (−0.069, 0.068) ALL −0.013 (−0.077, 0.047) −0.005 (−0.052, 0.039) 0.002 (−0.056, 0.059) Endosteal adjusted for periosteal circumference Male −0.083

(−0.161, -0.007) 0.43 −0.097 (−0.164, -0.031) 0.17 −0.127 (−0.214, -0.045) 0.13 Female −0.044 (−0.100, 0.014) −0.036 (−0.087, 0.018) −0.043 (−0.106, 0.020) ALL −0.062 (−0.108, selleck chemicals -0.015) −0.064 (−0.105, -0.022) −0.080 (−0.132, -0.029) Cortical thickness Male 0.117 (0.006, 0.228) 0.39 0.131 (0.039, 0.226) 0.21 0.180 (0.061, 0.306) 0.13 Female 0.054 (−0.029, 0.137) 0.054 (−0.021, 0.126) 0.061 (−0.029, 0.151) ALL 0.084 (0.014, 0.152) 0.089 (0.031, 0.148) 0.114 (0.041, 0.190) Table shows associations between plasma concentration of 25(OH)D3 and 50% tibial pQCT parametres at age 15.5 years. Beta coefficients represent SD change in pQCT parametre per doubling of vitamin 25(OH)D3. 95% Confidence intervals are presented with respect to the beta coefficients, P value (sex) shows the Selleck ATR inhibitor difference in associations between males and females. Results are also shown for the following

adjustments: minimally HSP inhibitor adjusted=sex, season of 25(OH)D3 measurement and age at scan; anthropometry-adjusted=minimally adjusted+height, loge fat mass and lean mass; anthropometry-, SES- and PA-adjusted=anthropometry adjusted+maternal and paternal social class, maternal education, and physical activity. All analyses were adjusted for vitamin 25(OH)D2 Subsequently, we compared associations between 25(OH)D2 and pQCT parametres as shown in Table 3, with associations between 25(OH)3 and pQCT parametres as shown in Table 4. P values for differences in these associations are shown in Table 5, for minimally and more fully adjusted models. In the case of BMDC and cortical bone area, there was weak evidence of a difference between 25(OH)D2

and 25(OH)D3 in fully adjusted models, P = 0.1 and P = 0.07, respectively, Carnitine palmitoyltransferase II boys and girls combined (Table 5). For BMCC, there was moderate evidence of a difference between 25(OH)D2 and 25(OH)D3 P < 0.05 in all models, boys and girls combined. There was strong evidence of difference between 25(OH)D2 and 25(OH)D3 in CT, endosteal adjusted for periosteal circumference and BR, P < 0.001 in minimal and more completely adjusted models, boys and girls combined. Apart from weak evidence of a difference in girls in our anthropometry-adjusted model (P = 0.04), there was no evidence of a difference between 25(OH)D2 and 25(OH)D3 with respect to periosteal circumference. No difference was observed for any model in respect of associations between 25(OH)D2 and 25(OH)D3 and cross-sectional moment of inertia, section modulus and strength strain index (results not shown).